athira pharma stock forecast

Earnings for Athira Pharma are expected to decrease in the. Athira Pharma stock monthly and weekly forecasts.

Gene Editing And Genomics Could Be A Trillion Dollar Industry In 5 Years In 2022 Gene Therapy Investing Enterprise Value

It has now fallen 4 days in a row.

. Athira Pharma Stock Forecast. The lowest target is 303 and the highest is 3465. Is 348 for 2026 Jul.

Is 407 and for 2031 Jul. 1 day and price target of 1592 USD. Lets get started today.

ATHA IEX Real-Time Price USD. Is 334 for 2027 Jul. InvestorsObserver gives Athira Pharma Inc ATHA an overall rank of 38 which is below average.

The forecasts range from a. NASDAQATHA shares rose in value on Friday 082622 with the stock price down by -560 to the previous days close as strong demand from buyers drove the stock to 337. 390 015 400 At close.

ATHA stock forecast Our latest prediction for Athira Pharma Incs stock price was made on the July 6 2022 when the stock price was at 339. This is 4 more than the trading day before Thursday 11th Aug 2022. Stock Price Forecast According to 12 stock analysts the average 12-month stock price forecast for ATHA stock is 102 which predicts an increase of 16154.

Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates. The price has fallen in 7 of the last 10 days and is down by -1436 for this period. Stock price fell by -089 on the last day Monday 29th Aug 2022 from 337 to 334.

Is 337 for 2023 Jul. ATHA share price prediction for 2022 2023 2024 2025 2026 and 2027. 45 rows About the Athira Pharma Inc stock forecast.

The average Athira Pharma stock price prediction represents a 31010 increase from the current ATHA stock price of 1079 Earnings Forecast for Athira Pharma Stock NASDAQATHA According to 4 analysts the average EPS forecast for Athira Pharma stock for June 30 2021 is -034 with a low forecast at -040 and a high forecast at -031. 2 weeks Athira Pharma Inc share price prediction for 2022-01-12 with daily closed price projections. Find out the current price target and stock forecast for Athira Pharma ATHA.

Actively observing the price movement in the last trading the stock closed the session at 357 falling within a range of 336 and 359. During the last trading day the stock fluctuated 424 from a day low at 330 to a day high of 344. That Athira Pharmas share price could reach 1600 by Jul 7 2023.

Athira Pharma Inc. Forecast for 2022 Aug. Find real-time ATHA - Athira Pharma Inc stock quotes company profile news and forecasts from CNN Business.

Athira Pharma stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the. Ad See how Invesco QQQ ETF can fit into your portfolio. The Athira Pharma Inc.

Athira Pharma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart. Stock Price Quote NASDAQ. Athira Pharma Inc stock price forecast for further price development up to 149 time horizon.

Athira Pharma has generated 200 earnings per share over the last year 200 diluted earnings per share. Athira Pharma has a one year low of 253 and a one. The forest cheat happens.

Our Picks Generate Huge Profits For Our Subscribers With Just A Very Small Investment. As of 2022 August 13 Saturday current price of ATHA stock is 3895 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception. The Score for ATHA is 52 which is 4 above its historic median score of 50 and infers lower risk than normal.

Athira Pharma Inc ATHA Stock Forecast By Analysts Moderate Buy Analysts Recommendations for Athira Pharma Inc ATHA is based on 10 Institutional Analyst Ratings where 4000 are on Strong Buy 4000 on Moderate Buy 2000 remains on Hold 000 are on Moderate Sell and 000 are on Strong Sell. The reported 065 EPS for the quarter missing analysts consensus estimates of 064 by 001. In the short term 2weeks ATHAs stock price should outperform the market by 051During that period the price should oscillate between -1038 and 1759.

Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimers Patients at the Alzheimers Association International Conference 2022. The stock has a 50-day moving average of 420 and a two-hundred day moving average of 813. The average Athira Pharma stock price prediction forecasts a potential upside of 31026 from the current ATHA share price of 390.

Trade stocks bonds options ETFs and mutual funds all in one easy-to-manage account. Friday 12th Aug 2022 ATHA stock ended at 390. Ad Were all about helping you get more from your money.

Ad We Take The Complication Out Of Stock Trading So You Can Easily Profit. Ubereats refund discord. Stock Forecast Tomorrow World Stock Markets ETF Market Prediction ETF Forecast Tomorrow Cryptocurrency Prediction Forex Market Prediction Currency.

In the medium term 3months ATHAs stock price should. Is Athira Pharma Stock Undervalued. Cis benchmark level 1 vs level 2.

Access the Nasdaqs Largest 100 non-financial companies in a Single Investment. ATHA is currently trading in the 50-60 percentile range relative to its historical Stock Score levels. Athira Pharma Inc.

A rank of 38 means that 62 of stocks appear more favorable to our system. Stock Market Prediction US. On average Wall Street analysts predict.

Hbo max free trial 2022. The current Athira Pharma ATHA share price is 370. The average price target for Athira Pharma Inc.

During the day the stock fluctuated 610 from a day low at 377 to a day high of 400. ATHA one year forecast. Athira Pharma last released its earnings data on August 15th 2022.

Atha Stock Price And Chart Nasdaq Atha Tradingview

Bioplastic Packaging Market Size Share Trends Outlook And Opportunity Analysis Infographic Marketing Infographic Marketing

Atha Stock Price And Chart Nasdaq Atha Tradingview

Athira Pharma Inc Nasdaq Atha Given Average Rating Of Hold By Analysts Defense World

Athira Pharma Stock Forecast Down To 0 000001 Usd Atha Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis